Description
WZ4002 is a novel, mutant-selective inhibitor of EGFR for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.
WZ4002 inhibits other EGFR genotypes E746_A750 and E746_A750/T790M with IC50 of 2 and 6 nM. Besides, WZ4002 suppresses widetype ERBB2 with an IC50 of 32 nM. WZ4002 inhibits
EGFR, AKT and ERK1/2 phosphorylation in NSCLC cell lines and WZ4002 prevents of EGFR phosphorylation in NIH-3T3 cells expressing different EGFR T790M mutant alleles. For WZ4002, kinases that
exhibited greater than 95% inhibition relative to the DMSO control at 10 μM are selected for measurement of their dissociation constants. WZ4002, which possesses an ortho-methoxy group at
the C2-aniline substituent, is more selective for EGFR compared to WZ3146. WZ4002 is 100-fold less effective at inhibiting phosphorylation of WT EGFR compared to the quinazoline inhibitors.
Similarly, WZ4002 prevents EGFR kinase activity of recombinant L858R/T790M protein more potently than of WT EGFR, while the opposite is observed with HKI-272 . In addition, the
phosphorylated EGFR of Src TKI-resistant H1975 cells, as well as HCC827 cells, is completely suppressed by the third generation EGFR TKI, WZ4002.
Application
Treatment with WZ4002 completely inhibited the growth of PC-9/Vec tumors, whereas treatment with E7050 did not (Fig. A). Treatment with either agent a lone slightly suppressed the
growth of PC- 9/HGF#5 t umor s ( Fig. B). Importantly, the combination of WZ4002 and E7050 reduced the size of PC-9/HGF#5 tumors(Fig.B).These results suggest that HGF can induce
resistance to WZ4002 in vivo and that this resistance can be overcome by E7050. In the second model, the growth of tumors induced by H1975 cells, which carry a T790M second mutation, was
inhibited by WZ4002 (Fig. C), In the third model, in which resistance was induced by Met amplification, monotherapy with either WZ4002 or E7050 partially inhibited the growth of HCC827ER
tumors(Fig. D)
Report:
Product name
|
WZ4002
|
CAS NO.
|
1213269-23-8
|
Synonyms
|
WZ4002
|
Category
|
Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals.
|
Purity
|
99% WZ4002
|
Appearance
|
WZ4002 powder
|
Shelf life
|
2 years
|
Usage
|
WZ4002 is an anticancer drug.
|
Storage
|
WZ4002 should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
|
Note
|
WZ4002 for R&D use only.
|
FEATURED PRODUCT:
Wuhan Newbio Pharm-tech Co., Ltd.
|
S#
|
CAS No.
|
Product Name
|
S#
|
CAS No.
|
Product Name
|
1
|
86639-52-3
|
7-Ethyl-10-Hydroxycamptothecin
|
25
|
183321-74-6
|
Erlotinib
|
2
|
154229-18-2
|
Abiraterone Acetate
|
26
|
183319-69-9
|
Erlotinib Hydrochloride
|
3
|
50-76-0
|
Actinomycin D
|
27
|
159351-69-6
|
Everolimus
|
4
|
106941-25-7
|
Adefovir
|
28
|
56296-78-7
|
Fluoxetine Hydrochloride
|
5
|
850140-72-6
|
Afatinib
|
29
|
184475-55-6
|
Gefitinib Hydrochloride
|
6
|
330784-47-9
|
Avanafil
|
30
|
136572-09-3
|
Irinotecan Hydrochloride
TriHydrate
|
7
|
319460-85-0
|
Axitinib
|
31
|
1441674-54-9
|
Ledipasvir(Acetone)
|
8
|
1421373-66-1
|
AZD-9291 (Mesylate)
|
32
|
191732-72-6
|
Lenalidomide
|
9
|
123524-52-7
|
Azelnidipine
|
33
|
21672
|
Methotrexate
|
10
|
863031-21-4
|
Azilsartan Medoxomil
|
34
|
76144-81-5
|
Mildronate
|
11
|
179324-69-7
|
Bortezomib
|
35
|
474645-27-7
|
Monomethyl Auristatin E
|
12
|
357336-20-0
|
Brivaracetam
|
36
|
63121-00-6
|
Oxaliplatin
|
13
|
842133-18-0
|
Canagliflozin
|
49
|
33069-62-4
|
Paclitaxel
|
14
|
928672-86-0
|
Canagliflozin HemiHydrate
|
37
|
137281-23-3
|
Pemetrexed Disodium
|
15
|
41575-94-4
|
Carboplatin
|
38
|
53123-88-9
|
Rapamycin
|
16
|
50935-04-1
|
Carubicin
|
50
|
135062-02-1
|
Repaglinide
|
17
|
288383-20-0
|
Cediranib
|
39
|
945667-22-1
|
Saxagliptin Hydrate
|
18
|
15663-27-1
|
Cisplatin
|
40
|
709031-78-7
|
Saxagliptin Hydrochloride
|
19
|
877399-52-5
|
Crizotinib
|
41
|
486460-32-6
|
Sitagliptin
|
20
|
171500-79-1
|
Dalbavancin
|
42
|
654671-77-9
|
Sitagliptin Phosphate Hydrate
|
21
|
114977-28-5
|
Docetaxel
|
44
|
85622-93-1
|
Temozolomide
|
22
|
148408-66-6
|
Docetaxel TriHydrate
|
45
|
477600-75-2
|
Tofacitinib
|
23
|
25316-40-9
|
Doxorubicin hydrochloride
|
46
|
540737-29-9
|
Tofacitinib Citrate
|
24
|
133040-01-4
|
Eprosartan
|
47
|
170791-09-0
|
Trityl Candesartan Cilexetil
|
ABOUT DELIVERY:
#1 Products can be sent out within 24 hours after payment.
#2 Secure and discreet shipment.
#3 Various methods for your choice, like DHL/FedEx/SF-express.
OUR COMMITMENT:
#1 We are manufacturer with own factory and we sale this product at a best quality and low price.
#2 All product listed is available in stock, please contact the sale for more details.
#3 We have QA&QC department to guarantees the quality, product pass
rate can reach 100%.
CONTACT US:
Telephone
|
+86-027-87002705
|
Mobile
|
+86-13277093700
|
|
newbiopharmtech
|
FaceBook Page
|
https://www.facebook.com/newbiopharma/
|
Facebook Group
|
https://www.facebook.com/groups/1739616069613416/
|
Website
|
http://www.newbiopharm.com/
|
Online Store
|
http://biocar.en.made-in-china.com/
|
If you want to source ...
#1 Pharmaceutical raw material,
#2 Oncology drug APIs,
#3 Antibiotics or fine chemicals,
We are a reliable manufacturer and supplier in China.
NEWBIO would like to ...
#1 We foucus on the high purity and high quality;
#2 We provide the raw materials at a good price;
#3 We have the best service and we are always there for you.
Please contact us for more infomation!!!